S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy
NCT02191566
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Stopped
The patient's study enrollment was too low.
Conditions
Stomach Cancer
Interventions
DRUG:
S-1 (452500ACH)
DRUG:
OXALIPLATIN (205803BIJ)
Sponsor
Kangbuk Samsung Hospital